AN2 Therapeutics
Latest round
- Series B
Last raised
- Jan 2022
Total raised
- $92M
Investors
- 10
About AN2 Therapeutics
Based in California, AN2 Therapeutics, Inc.AN2 Therapeutics, Inc. was founded in 2017 and is headquartered in Menlo Park, California, US. The company specializes in innovative therapeutics for chronic infectious diseases. Eric Easom and Joe Zakrzewski are the founders, with Eric Easom currently serving as CEO.00 mn.AN2 Therapeutics specializes in developing novel therapies targeting rare, chronic, and serious infectious diseases through its advanced boron-based chemistry platform.AN2 Therapeutics generates revenue through partnerships and collaborations with pharmaceutical companies and healthcare organizations. Their revenue model includes milestone payments, royalties, or licensing agreements associated with the development and commercialization of their therapeutic offerings. The company aims to further develop its pipeline and expand its presence in the therapeutic landscape for infectious diseases and oncology, although specific new product launches and market expansions have not been detailed.
Who invested in AN2 Therapeutics
10 investors across 2 rounds
See all investors in AN2 Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about AN2 Therapeutics
Who invested in AN2 Therapeutics?
AN2 Therapeutics has 10 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has AN2 Therapeutics raised?
AN2 Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did AN2 Therapeutics last raise money?
AN2 Therapeutics's most recent round on record is a Series B, in Jan 2022.
What does AN2 Therapeutics do?
Based in California, AN2 Therapeutics, Inc.
Where is AN2 Therapeutics headquartered?
AN2 Therapeutics is headquartered in Menlo Park, US.
Which VCs invest in companies like AN2 Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at AN2 Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like AN2 Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.